{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-071011","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.593291+00:00","generated_at":"2026-06-01T04:35:30.181154+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Annovis Bio stockholders elect directors, approve equity plan amendment, ratify auditors at annual meeting","bullets":["All five director nominees elected; Michael Hoffman (3,856,586 for), Maria Maccecchini (3,888,261 for), Claudine Bruck, Reid McCarthy, Mark White.","Amendment to 2019 Equity Incentive Plan approved, adding 1,000,000 shares to the share reserve.","Ratification of Ernst & Young as independent auditor for FY2024 approved (7,214,275 for, 48,270 against).","66.10% of outstanding shares (7,278,396 shares) were represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-071011","json":"https://secwatch.observer/filing/0001104659-24-071011.json","markdown":"https://secwatch.observer/filing/0001104659-24-071011.md","text":"https://secwatch.observer/filing/0001104659-24-071011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924071011/0001104659-24-071011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924071011/tm2417098d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:35:30.181154+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}